New results from the POSITIVE trial highlight the need to assess hormonal factors when advising breast cancer patients pausing endocrine therapy for pregnancy.
Our findings reinforce the value of comprehensive fertility counseling and close collaboration with reproductive specialists to align cancer care with family planning
Donating & Supporting